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Objective: The advantages of hyperpolarizing cardioplegia with potassium-channel
openers versus depolarizing cardioplegia have been suggested but not demonstrated
in coronary microarteries. This study examined the simultaneous electric and tonic
alteration of coronary microarteries at the cellular level during and after exposure to
depolarizing cardioplegia or hyperpolarizing cardioplegia, with emphasis on endo-
thelium-derived hyperpolarizing factor–mediated relaxation and hyperpolarization.
Methods: Porcine coronary microarteries (diameter, approximately 200-400 m)
were incubated with depolarizing cardioplegia (20 mmol/L KCl) or hyperpolarizing
cardioplegia (10 mol/L aprikalim) for 1 hour. Cellular membrane potential with a
glass microelectrode in a coronary smooth muscle cell and isometric force of the
muscle were simultaneously measured in a myograph.
Results: Depolarizing cardioplegia incubation produced a stable contraction (from
4.9  0.3 mN to 7.3  0.4 mN) and depolarization (from 51  1 mV to 41 
2 mV). In contrast, hyperpolarizing cardioplegia relaxed (from 4.8  0.3 mN to 3.5
 0.3 mN) and hyperpolarized (from 51  2 mV to 56  1 mV) the smooth
muscle. After exposure to depolarizing cardioplegia, the bradykinin-induced, endo-
thelium-derived hyperpolarizing factor–mediated relaxation reduced from 66.2% 
5.0% to 18.4%  3.7% (P  .001), and the membrane hyperpolarization reduced
from 18  1 mV to 7  1 mV (P  .001) in the presence of indomethacin and
NG-nitro-L-arginine. In contrast, hyperpolarizing cardioplegia did not affect the
bradykinin-induced responses.
Conclusions: In the coronary microarteries, exposure to hyperpolarizing cardiople-
gia preserves whereas depolarizing cardioplegia reduces the endothelium-derived
hyperpolarizing factor–mediated electric (hyperpolarization) and mechanical (relax-
ation) responses. Thus hyperpolarizing cardioplegia is superior to depolarizing
cardioplegia in protecting the endothelial function in the coronary microcirculation.
Use of depolarizing cardioplegia (DC) is the most common methodfor myocardial preservation in cardiac surgery.1 Potassium (K)at high concentrations (hyperkalemia, usually containing 10-20mmol/L K) is the major depolarizing agent in cardioplegia.Despite the cardioprotective effect, DC causes depolarization ofthe membrane potential by means of extracellular hyperkalemia,
resulting in energy storage depletion and calcium overload,2 ongoing cellular
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metabolic processes and derangements in transmembrane
ionic gradients,2 influx of sodium through the sodium “win-
dow current,” exchange of intracellular sodium for calcium
through the sodium-calcium exchange, influx of calcium
through the calcium window current,3 and leakage of cal-
cium from the sarcoplasmic reticulum. These factors con-
tribute to myocardial calcium overload, which is related to
myocardial injury during the arrest,4 with clinical evidence
of ventricular dysfunction.3-5 Moreover, DC has deleterious
effects on coronary endothelium6,7 and might cause coro-
nary vasospasm,8,9 leading to suboptimal myocardial recov-
ery after cardiac surgery.
Because of these considerations, hyperpolarizing cardio-
plegia (HC) has been proposed for cardiac arrest during
cardiac surgery.10-12 The natural resting state of the cardiac
myocyte is at hyperpolarized membrane potentials.10 Few
channels or pumps are activated at hyperpolarized poten-
tials, and there is little metabolic demand on the ventricular
myocyte at this status.
Potassium-channel openers (KCOs) have been suggested
to be used for cardioprotection.10-15 Adenosine triphosphate
(ATP)–sensitive potassium-channel openers inhibit the de-
velopment of myocardial contracture, reduce the release of
lactate dehydrogenase, and preserve intracellular ATP con-
tent during ischemia.16 Because of the hyperpolarizing ef-
fect of KCOs on the membrane potential of myocytes,
cardioplegia with KCOs has been defined as HC12 and has
significantly prolonged the period to the development of
myocardial contracture12,14 and afforded a significantly bet-
ter postischemic recovery of function than DC arrest.12 In
addition, KCOs hyperpolarize the membrane potential of
the smooth muscle, subsequently affecting voltage-operated
calcium channels and intracellular calcium release, and re-
lax the vessel16,17 that obviously facilitates the myocardial
perfusion.
Endothelium-dependent relaxation is known to be due to
nitric oxide (NO), prostacyclin, and endothelium-derived
hyperpolarizing factor (EDHF). The nature of EDHF has
not been finally identified, although many substances, such
as epoxyeicosatrienoic acid, anadamide, K, H2O2, citrul-
line, NH3, and ATP have been suggested to be the candi-
dates for EDHF.18 EDHF induces vascular smooth muscle
relaxation through hyperpolarization of the smooth muscle
cells,18-20 which might involve K channels.19,21 In con-
trast, NO mainly relaxes blood vessels through the cyclic
guanosine monophosphate pathway.22
Our previous studies have demonstrated that in large
conductance coronary arteries, DC (hyperkalemia, 20-50
mmol/L K), but not HC, reduces the EDHF-mediated
relaxation. The present study was designed to examine (1)
the effect of HC versus DC in the coronary resistance
arteries (microarteries) and (2) the relaxation-associated
electrophysiologic changes of the cellular membrane poten-
tial in the microartery.
Methods
Preparation and Mounting of Coronary Microarteries
Fresh porcine hearts collected from a local slaughterhouse were
placed in a container filled with cold Krebs’ solution and imme-
diately transferred to the laboratory. On receipt of the hearts, the
intramyocardial coronary arteries (usually the tertiary branches of
the left anterior descending artery) were carefully dissected in
Krebs’ solution under a microscope, with great care taken to
protect the endothelium. These are proximal resistance arteries
(microarteries). The vessel was cleaned of fat and connective
tissue and cut into 2 cylindrical rings under a microscope, each of
which was 2 mm long. A suitable length of stainless-steel wire (40
m in diameter) was guided through the lumen of each ring. The
wire was fixed tightly on a jaw in a 2-channel myograph (model
500A; J. P. Trading, Aarhus, Denmark), and another wire was
passed lightly through the lumen and then anchored to the other
jaw of the same chamber. These 2 wires were attached to either a
force transducer or a micrometer. A calibrated force transducer
was used to measure the force, with the output shown on a
computer screen, and the graphs were printed on a printer. Data
were digitized and stored in the computer. Two organ-chamber
arrangements were run concurrently.
The Krebs solution was aerated with a gas mixture of 95%
O2–5% CO2 at 37°C  0.1°C and had the following composition:
NaCl, 118.4 mmol/L; KCl, 4.7 mmol/L; MgSO4.7H2O, 1.2
mmol/L; KH2PO4, 1.2 mmol/L; NaHCO3, 25 mmol/L; ()-glu-
cose, 11.1 mmol/L; and CaCl2.2H2O, 2.5 mmol/L. This gives the
following final molar concentration: Na, 143.4 mmol/L; K, 5.9
mmol/L; Ca2, 2.5 mmol/L; Mg2, 1.2 mmol/L; Cl, 128.7
mmol/L; HCO3, 25 mmol/L; SO42 1.2 mmol/L; H2PO4, 1.2
mmol/L; and glucose, 11.1 mmol/L.
Normalization
A previously described method23 was used to normalize vascular
rings under a pressure simulating the conditions encountered in the
coronary microarteries at their normal transmural pressure accord-
ing to their own length-tension curves. After equilibration at 37°C
 0.1°C for 30 minutes, the arterial rings were progressively
stretched until the passive transmural pressure reached 100 mm
Hg, and the pressure was then immediately released. The internal
circumference was then set to a normalized value estimated to be
equivalent to 90% of the circumference at a passive transmural
pressure of 100 mm Hg throughout the experiment. The isometric
force at this setting is the passive, or resting, force in the absence
of contraction tone that is similar to a physiologic pressure, and
this has been shown to allow maximum tension development. Only
arterial rings of 200 to 400 mol/L in internal diameter at the
transmural pressure of 100 mm Hg were used in this study.
Simultaneous Measurement of Isometric Force and
Membrane Potential
The myograph was placed in a metal screen cage (Farady cage).
The arterial rings were mounted on the myograph and normalized
as mentioned above. A conventional glass microelectrode filled
with 3 mol/L KCl (tip resistance, 100-120 M) was advanced by
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using a pipette holder mounted on a 3-dimensional vernier-type
hydraulic micromanipulator and inserted into a single smooth
muscle cell from the adventitial surface of the rings. This setting
allows simultaneous measurement of isometric force and the mem-
brane potential contributing to this force production.19,24 The
electrical signals were amplified by means of a battery-operated,
low-noise, wide-band electrometer preamplifier (World Precision
Instruments, New Haven, Conn). The membrane potential was
monitored continuously on a dual-trace oscilloscope (Maxtec In-
ternational Corporation, Chicago, Ill) and simultaneously recorded
in a computer. The following criteria were used to assess the
validity of a successful impalement into a cell: (1) a sudden
negative shift in voltage, followed by (2) a stable negative voltage
for more than 2 minutes and (3) an instantaneous return to the
previous voltage level on dislodgement of the microelectrode.19,24
The recording of the membrane potential was taken simulta-
neously with the recording of force changes by using the myo-
graph recording system.
Protocol
After normalization, the rings were equilibrated for 30 minutes and
incubated with Krebs solution (control), with the HC containing 10
mol/L aprikalim or DC containing 20 mmol/L K (replacement
of Na with 20 mmol/L K in Krebs solution). After incubation at
37°C  0.1°C for 60 minutes, the rings were repeatedly washed
with normal Krebs solution and equilibrated for 30 minutes. In-
domethacin (a cyclooxygenase inhibitor, 7 mol/L) and NG-nitro-
L-argine (L-NNA; an inhibitor of NO synthase, 300 mol/L) were
added into the solution in the myograph chambers for 30 minutes
to inhibit the production of prostacyclin and NO. The rings were
contracted with the thromboxane A2 mimetic U46619 (3 mol/L).
When stable contractions and depolarization to U46619 were
reached, bradykinin was cumulatively added to establish concen-
tration-response curves.
Simultaneous recording of bradykinin-induced hyperpolar-
ization and relaxation in coronary microarteries: Group 1 (n 
7-10 in each subgroup). The isometric force and membrane po-
tential of coronary smooth muscle cells were simultaneously mea-
sured during the period of incubation with DC or HC, equilibration
after washout with Krebs solution, contraction with the U46619,
and relaxation with bradykinin at the concentrations of –10 to –7
log mol/L, with 1 log unit increments. A total of 26 arterial rings
successfully completed all abovementioned simultaneous mea-
surements of membrane potential, and isometric forces were ana-
lyzed. Among them, 7 rings were treated with HC, 9 with DC, and
10 were used for control purposes. The rings were excluded from
data analysis if we were unable to simultaneously measure the
relaxation and hyperpolarization induced by cumulative addition
of bradykinin (0.1 nmol/L to 0.1 mol/L) because of either un-
successful implementation of the electrode or unsuccessful main-
tenance of the electrode intracellularly for the whole period of the
dose-response curves for bradykinin. Only one concentration-re-
sponse (relaxation or repolarization-hyperpolarization) curve was
established from each coronary ring. From 7 to 10 rings in each
group, a mean concentration-response curve was established.
Full concentration-relaxation curves for bradykinin after ex-
posure to HC or DC compared with control rings: Group 2 (n 
7 in each subgroup). In this group of experiments, each coronary
microartery contributed to 2 rings. One was used as a control, and
the other was incubated with either HC or DC for 1 hour, as in
group 1. Therefore in this group each ring treated with either HC
or DC had its own control ring taken from the same microartery.
Bradykinin-induced relaxation in the U46619 precontraction was
established with concentrations of 10 to 6.5 log mol/L in
half-log unit increments in each ring. The group data were from 7
rings.
Data Analysis
Relaxation was expressed as the percentage of decrease in isomet-
ric force induced by U46619. Hyperpolarization (repolarization)
was reported as the reduced amplitude of the membrane potential
(depolarization) with U46619. The mean maximal relaxation for
each group was calculated from group data. The effective concen-
tration of bradykinin that caused 50% of maximal relaxation was
defined as the EC50. The EC50 was determined from each concen-
tration-relaxation curve by using a logistic, curve-fitting equation:
EMAp/(Ap Kp),
where E is response, M is maximal relaxation, A is concentration,
K is EC50 concentration, and P is the slope parameter.20,23 From
this fitted equation, the mean EC50 value was calculated from each
group.
Data are expressed as means 1 SEM for n observations,
where n equals the number of coronary arterial rings. The data
were analyzed with paired and unpaired t tests and analysis of
variance (followed by the Scheffe F test) when appropriate.
Drugs
Drugs used and their sources were as follows: bradykinin, L-NNA,
and indomethacin were from Sigma chemical Co, St Louis, Mo.
Aprikalim was a gift from Rhoˆne-Poulenc Rover, Centre De Re-
cherche de Vitry-alfortrille, France. U46619 was from Cayman
Chemical, Ann Arbor, Mich. L-NNA (dissolved in distilled water)
and indomethacin (dissolved in ethanol) were stored at 4°C. The
solution of U46619 was held frozen until required.
Results
Baseline Characteristics of Coronary Microarteries
The internal diameter of the coronary microarteries at a
transmural pressure of 100 mm Hg was 349  11 mol/L
(n  10) in the control group, 349  10 mol/L (n  9) in
the DC group, and 345  13 mol/L (n  7) in the HC
group (P  .05). After normalization, the resting force of
vascular rings was 4.8  0.3 mN in the control group, 4.9
 0.4 mN in the DC group, and 4.7  0.2 mN in the HC
group (P  .05). The resting membrane potential of coro-
nary smooth muscle cells was 52  2 mV in the control
group, 52  2 mV in the DC group, and 51  1 mV in
the HC group (P  .05). There were no significant differ-
ences (P  .05) in the internal diameters, resting tones, and
resting membrane potentials among the 3 groups.
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Tonic and Electric Alteration of Coronary
Microarteries During Exposure to DC and HC and
After Washout
Addition of DC with 20 mmol/L KCl induced a contraction
of coronary microarteries (7.3  0.4 mN, n  9, P  .001
vs the resting tone), and the membrane potential was depo-
larized to 41  2 mV (P  .002 vs the resting membrane
potential, Figure 1).
Incubation with HC produced a rapid and stable relax-
ation of coronary rings. The reduction in force caused by
HC was associated with a change in membrane hyperpolar-
ization (Figure 1). When the relaxation reached a sustained
plateau, the force and membrane potential simultaneously
recorded were 3.5 0.3 mN (n 7, P .007 vs the resting
tone) and 56  1 mV (P  .03 vs the resting membrane
potential), respectively.
At 30 minutes after washout, there were no significant
differences in isometric force and membrane potential of
coronary smooth muscle cells between the HC or DC
groups and the control group (P  .05).
U46619-Induced Contraction and Depolarization
After coronary rings were incubated with indomethacin and
L-NNA for 30 minutes, addition of 3 nmol/L U46619 pro-
duced a stable and rapidly developing contraction in the HC,
DC, and control groups. Simultaneously, a depolarization
was recorded. The U46619-induced contraction force and
associated membrane potential were 7.5  0.5 mN and
27.6  2 mV in the control group, 7.8  0.8 mN and
27.5  2.1 mV in the DC group, and 7.1  0.8 mN and
25.9  3.3 mV in the HC group, respectively. No differ-
ences existed among the 3 groups in the U46619-induced
contraction forces (P  .6) and membrane potentials (P 
.7, analysis of variance).
Simultaneous Recording of Bradykinin-Induced
Relaxation and Hyperpolarization in Coronary
Microarteries (Group 1)
In the presence of indomethacin and L-NNA, when U46619-
induced contraction reached a stable plateau, cumulative
addition of 10 to 7 log mol/L bradykinin (0.1 nmol/L to
0.1 mol/L) induced a simultaneous relaxation and hyper-
polarization of coronary microarteries in a concentration-
dependent manner (Figure 2). In the control rings the bra-
dykinin-induced maximal relaxation and associated
hyperpolarization were 68.0% 4.9% and 18 1 mV (n
10), respectively. HC treatment (n  7) did not affect the
bradykinin-induced relaxation and associated membrane
hyperpolarization (Figure 2, A). However, DC treatment
significantly reduced the bradykinin-induced relaxation and
hyperpolarization at the concentrations of 9 to 7 log
mol/L (1 nmol/L to 0.1 mol/L; Figure 2, B). The maximal
relaxation and hyperpolarization decreased to 18.4% 
3.7% and 9.0  1.0 mV (n  9, P  .001), respectively.
Figure 3 shows the group data.
Concentration-Relaxation Curves for Bradykinin After
Exposure to HC or DC Compared With Control
Rings: Group 2
The concentration-relaxation curves for bradykinin in the
rings treated with HC or DC for 1 hour compared with their
own control rings treated with Krebs solution are shown in
Figure 4. Similar to group 1, in which simultaneous mea-
surement of isometric force and membrane potential was
performed, the concentration-dependent relaxation induced
by bradykinin was not altered by HC but was reduced by
Figure 1. Isometric force (A) and associated membrane potential
(B) of coronary microarteries during incubation with DC and HC.
Values are means 1 SEM. *P < .05, **P < .01, and ***P < .001
compared with the control.
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DC at concentrations of 9 to 6.5 log mol/L (1-316
nmol/L). The maximal relaxation was reduced from 69.3%
 3.2% (n  7) to 11.3%  2.4% (n  7, P  .001). In the
control group the EC50 for bradykinin was 21.3  6.9
nmol/L (n 7). HC (13.7 4.4 nmol/L) or DC (16.4 5.1
nmol/L) treatment did not affect the EC50 value for brady-
kinin (P  .05).
Discussion
The present study, done at the cellular level, has demon-
strated in the porcine coronary microarteries that (1) HC
with the KCO aprikalim hyperpolarizes and relaxes the
coronary microartery and preserves the EDHF-mediated
hyperpolarization and relaxation and (2) DC with 20
mmol/L KCl contracts and depolarizes the coronary smooth
muscle cells and reduces the EDHF-mediated hyperpolar-
ization and associated relaxation. Therefore the present
study suggests that HC is superior to DC regarding protec-
tion of the EDHF-mediated function in coronary microar-
teries.
Electrical and Mechanical Changes of Coronary
Microarteries During Incubation to Cardioplegia
In the present study incubation with DC (20 mmol/L KCl)
induced a stable contraction of coronary microarteries and
sustained depolarization of smooth muscle cells. This is
consistent with those obtained in cardiac myocytes25 and in
large coronary conduit arteries.6 Although there is no direct
evidence concerning how continuous depolarization affects
the transmembrane ion gradients in this vasculature, the
progressive depolarization of cardiac myocytes through ex-
tracellular hyperkalemia has been shown to produce an
intracellular accumulation of sodium, calcium, and chloride
ions.26 The derangements in these transmembrane ionic
gradients lead to the activation of relevant ionic pumps at a
considerable energy cost.26 Therefore the ongoing depolar-
Figure 2. Trace recording of simultaneous measurement of U46619-induced precontraction (force) and depolar-
ization (MP; A) and bradykinin (BK)–induced relaxation (force) and membrane hyperpolarization (B) of coronary
microarteries in the presence of indomethacin (7 mol/L) and L-NNA (300 mol/L).
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ization by DC undoubtedly produces unfavorable effects on
coronary microarteries.
In contrast, the incubation of HC containing aprikalim
results in vasodilation and membrane hyperpolarization in
the coronary microarteries. Aprikalim is a potent agent that
selectively opens ATP-sensitive potassium-channels.16,17,27
In the blood vessel28 and in the cardiac myocyte,29 the
opening of ATP-sensitive potassium-channels leads to the
outward current of K and membrane hyperpolarization,
and therefore incubation of HC containing aprikalim leads
to membrane hyperpolarization of vascular smooth muscle
cells in the coronary microarteries.
Alteration of EDHF-Mediated Function in Coronary
Microarteries After Exposure to Cardioplegia
As mentioned above, the endothelial cells release at least 3
relaxing mediators: NO, prostacyclin, and EDHF. Although
the chemical nature of EDHF remains unidentified, it is
known that this factor relaxes the smooth muscle cell
through electrical response (hyperpolarization) associated
with mechanical response (relaxation). The mechanism of
EDHF to relax the smooth muscle cell is therefore similar to
hyperpolarizing agents, such as KCOs, that can be used as
cardioplegia. In a previous study we demonstrated that HC
is superior to DC on the protection of the EDHF-mediated
relaxation in large coronary arteries. The present study was
designed to answer 2 further questions. First, the microcir-
culation in the coronary system accounts for at least 50% of
the total resistance. Therefore we asked whether the use of
HC or DC affects the endothelial function in the coronary
microcirocirculation. Second, regarding the mechanism of
the effect of cardioplegia on the endothelial function, the
only way to demonstrate the endothelium–smooth muscle
interaction through the EDHF pathway is to simultaneously
measure the electrical and mechanical responses in the
coronary microartery, but this has never been reported. In
particular, it is technically very difficult to simultaneously
measure the membrane potential of the smooth muscle cell
and the contraction-relaxation of the smooth muscle in the
microartery. In the present study we successfully measured
these 2 simultaneous parameters and clearly demonstrated
that the reduction of the EDHF-mediated relaxation in the
coronary microartery is associated with simultaneous reduc-
tion of the cellular membrane hyperpolarization. Therefore
the present study, for the first time, demonstrates the mech-
anism of the superiority of hyperpolarizing agents to depo-
larizing agents on the endothelial function.
NO and EDHF are the 2 major mediators for the endo-
thelium-dependent relaxation in the coronary artery.19,20
The present study has focused on the EDHF pathway and
investigated the effect of cardioplegia on the coronary mi-
croarterial endothelium, excluding the effect of ischemia
and reperfusion, to provide information on the composition
of cardioplegia. The effect of cardioplegia on NO produc-
tion and the combined effect with ischemia and reperfusion
are to be clarified.
Limitations of the Study
The present study investigated the effect of HC or DC as
crystalloid cardioplegia on a specific endothelium-derived
factor: EDHF-mediated function. The study was performed
in vitro. Although this is the best way to study the cellular
mechanisms (eg, membrane potential measurement), the
results cannot be directly transferred to the clinical setting.
Blood cardioplegia is now the well-accepted standard
Figure 3. Simultaneous measurement of bradykinin-induced re-
laxation in 1 log unit increments (A) and membrane hyperpolar-
ization (B) of coronary microarteries precontracted with U46619
in the presence of indomethacin (7 mol/L) and L-NNA (300
mol/L) in the control rings (n  10) and in rings treated with HC
(n  9) or DC (n  7). Values are presented as means 1 SEM.
*P < .05, **P < .01, and ***P < .001 compared with the control.
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method for cardioplegia in many cardiac centers because
constituents of the blood provide a variety of physiologic
protection mechanisms not found in pure crystalloid solu-
tions. The present study therefore should be considered to
be a study on a specific mechanism among many factors.
Conclusions
In the present in vitro study, done at the cellular level, the
incubation with depolarizing cardioplegia (20 mmol/L KCl)
induces contraction and depolarization of porcine coronary
microarteries and reduces the subsequent EDHF-mediated
hyperpolarization and associated relaxation, even after
washout of the cardioplegia. In contrast, incubation with HC
(the KCO aprikalim) simultaneously relaxes and hyperpo-
larizes the coronary microvascular smooth muscle and pre-
serves the EDHF-mediated function. Thus HC with
aprikalim is superior to hyperkalemic DC in the protection
of endothelial function in the coronary microartery.
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